Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
      1362 results
    
    - 
  
    
$7 million for research into neurofibromatosisThe Australian Government is providing $7 million through the Medical Research Future Fund for research into neurofibromatosis.
- 
  
    
Medicare Benefits Schedule Electrocardiogram review committee – call for expressions of interest to participateClinicians, academics and consumers are invited to express their interest in participating in the MBS ECG Review Committee, which will review changes to MBS ECG items introduced on 1 August 2020 following implementation of recommendations from the MBS Review Taskforce.
- 
  
    
COVID-19 vaccine information and resources for aged care providersNew information about the COVID-19 vaccine rollout to residential aged care facilities is now available.
- 
  
    
Prime Minister’s update following the National Cabinet meeting on 5 February 2021Read the Prime Minister’s update following the National Cabinet meeting on 5 February 2021.
- 
  
    
Share your views on making mitochondrial donation available in AustraliaWe invite you to share your views on the proposed approach to making mitochondrial donation available in Australia. The government wants to introduce mitochondrial donation so this lifesaving technology is made available in Australia for some families impacted by severe mitochondrial disease.
- 
  
    
10 million additional Pfizer-BioNTech vaccines securedAustralia has secured an extra 10 million doses of the Pzifer/BioNTech COVID-19 vaccine, bringing the total number of doses of this vaccine to 20 million.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) updated statement on minimising the potential risk of COVID-19 transmission in schoolsAn updated statement from the Australian Health Protection Principal Committee (AHPPC) on on minimising the potential risk of COVID-19 transmission in schools.
- 
  
    
$1.9 billion to go towards COVID-19 vaccine rolloutThe Prime Minister has outlined plans to deliver Australia's COVID-19 vaccination program this year. Find out more.
- 
  
    
New information campaign to encourage Australians to get a COVID-19 vaccineA campaign to encourage Australians to get the COVID-19 vaccine has begun.
- 
  
    
Reminder: Free vaccinations for students in high schoolStudents in years 7 (year 8 in South Australia) and 10 can receive free vaccinations at school through the National Immunisation Program. Trained and qualified vaccination teams will visit schools to deliver the vaccines throughout the year.
- 
  
    
Important changes to the National Cervical Screening Program's Clinical Guidelines pathway for women at intermediate riskChanges to the NCSP's Guidelines for the clinical management of women at intermediate risk will come into effect from 1 February 2021. This follows the Cancer Council Australia Clinical Guidelines working party review of national data from the renewed program.
- 
  
    
TGA provisionally approves Pfizer/BioNTech COVID-19 vaccine for use in AustraliaThe Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 vaccine for use in Australia.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on COVID-19 and influenza vaccination requirements for aged care workersA statement from the Australian Health Protection Principal Committee (AHPPC) on COVID-19 and influenza vaccination requirements for aged care workers.
- 
  
    
Prime Minister’s update following the National Cabinet meeting on 20 January 2021Read the Prime Minister’s update following the National Cabinet meeting on 20 January 2021.
- 
  
    
COVID-19 vaccine rollout: Primary care participation in Phase 1b–call for expressions of interest from General PracticesAccredited general practices are invited to express their interest in participating in Phase 1b of the COVID-19 Vaccination Program.
- 
  
    
$38 million for diabetes and heart disease researchThe Medical Research Futures Fund will fund two new research centres to address diabetes and heart disease.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on safe air travel – enhancing end-to-end mitigations – internationalAustralian Health Protection Principal Committee (AHPPC) statement on safe air travel – enhancing end-to-end mitigations – international.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on management of COVID-19 variantsFrom 7 January 2021, additional precautions will be put in place to manage new variants related to COVID-19.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on wearing masks on domestic flightsA statement from the Australian Health Protection Principal Committee (AHPPC) on wearing masks on domestic flights.
- 
  
    
Prime Minister’s update following the National Cabinet meeting on 8 January 2021Read the Prime Minister’s update following the National Cabinet meeting on 8 January 2021.
- 
  
    
Australia's COVID-19 vaccine national roll-out strategy announcedThe Australian Government has announced Australia's COVID-19 vaccine national roll-out strategy.
- 
  
    
Review of Continuous Glucose Monitoring productsThe Australian Government will be conducting a review of continuous glucose monitoring (CGM) products under the CGM Initiative.
- 
  
    
$10 million to support COVID-19 related clinical trialsThe Australian Government is providing $10.1 million under the Medical Research Future Fund (MRFF) for clinical trials related to COVID-19.
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on Australia’s National Hotel Quarantine PrinciplesAustralian Health Protection Principal Committee (AHPPC) statement on Australia’s National Hotel Quarantine Principles
- 
  
    
Australian Health Protection Principal Committee (AHPPC) statement on mandatory quarantine for aircrew who are not local residentsA statement from the Australian Health Protection Principal Committee (AHPPC) on mandatory quarantine for aircrew who are not local residents.